ArticleAsia Pacific allergy2026
Prevalence and influencing factors of allergic rhinitis in Xi'an: A 2022 survey.
Article in Asia Pacific allergy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The incidence of allergic rhinitis (AR) has been rising annually in China, correlating with the ongoing intensification of global climate change and industrialization. Objectives: This study aimed to investigate the self-reported prevalence of AR among adults in Xi'an, as well as the relevant influencing factors. Methods: The prevalence of AR was assessed among adult residents across 11 districts of Xi'an from June to October 2022. Additionally, an analysis was conducted to determine the relevant influencing factors associated with AR in these patients. Results: In total, 3,350 individuals from 11 districts in Xi'an participated in this survey, with a self-reported prevalence of 10.0%. Among AR patients, 20.1% had a family history of allergies, compared with 5.1% in those without AR. The prevalence of AR was 30.3% in patients with a family history of allergies and 8.5% in those without. Urban residents had a higher prevalence of AR (11.0%) than suburban residents (8.3%) ( Conclusion: The incidence of AR in Xi'an remained high. This study will enhance the understanding of AR patterns in Xi'an and inform public health policies, prevention strategies, and AR control systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.